P946: TOCILIZUMAB PRE-TREATMENT SIGNIFICANTLY REDUCES THE INCIDENCE OF CYTOKINE RELEASE SYNDROME IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE CEVOSTAMAB
oleh: Maria-Victoria Mateos, Nizar J Bahlis, Andrew Spencer, Rayan Kaedbey, Paula RodrÃguez-Otero, Simon Harrison, Chihunt Wong, Grant Goodman, Rin Nakamura, Voleak Choeurng, James Cooper, Suzanne Trudel
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2023-08-01 |
Deskripsi
No description available for this item.